Cargando…

A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran

Objective: The purpose of the present study was a survey of venous thromboembolism (VTE) prophylaxis in obstetrics patients in Iran. Materials and methods: A national, multicenter, non-interventional, prospective study was performed on 1000 women at 11 different parts of Iran. Primary outcome was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokhtari, Majid, Nasri, Khadijeh, Tara, Fatemeh, Zarean, Elahe, Hantoushzadeh, Sedigheh, Radmehr, Mehrnaz, Kashanian, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911145/
https://www.ncbi.nlm.nih.gov/pubmed/31850094
_version_ 1783479215673311232
author Mokhtari, Majid
Nasri, Khadijeh
Tara, Fatemeh
Zarean, Elahe
Hantoushzadeh, Sedigheh
Radmehr, Mehrnaz
Kashanian, Maryam
author_facet Mokhtari, Majid
Nasri, Khadijeh
Tara, Fatemeh
Zarean, Elahe
Hantoushzadeh, Sedigheh
Radmehr, Mehrnaz
Kashanian, Maryam
author_sort Mokhtari, Majid
collection PubMed
description Objective: The purpose of the present study was a survey of venous thromboembolism (VTE) prophylaxis in obstetrics patients in Iran. Materials and methods: A national, multicenter, non-interventional, prospective study was performed on 1000 women at 11 different parts of Iran. Primary outcome was to assess the situation of VTE prophylaxis in pregnant and postpartum women and the secondary outcome was risk stratification in obstetrics patients and to evaluate the guideline adherence in physician’s practice of VTE prophylaxis. Results: 1,036 women entered the final analysis. The three main VTE risk factors before hospitalization were BMI > 30 kg/m2, history of oral contraceptive (OCP) use, and the age over 35.VTE risk factors upon enrollment were detected in 780 (75.28%) patients. 219 women (28.07%) were deemed eligible for drug prophylaxis, however, only 37 women (17%) received it. A total of 113 (10.9%) patients received VTE prophylaxis, of which 76 (67.25%) women had no clear indications. Concordance between theory and practice was detected with a Cohen’s Kappa coefficient to be 0.74 (p < 0.001), which fell within “good agreement”. Multivariate analysis for association between VTE prophylaxis and VTE risk factors showed that history of VTE [OR = 9.06 (CI 95% 1.16 – 70.8) p = 0.036] was the most frequent risk factor for receiving VTE prophylaxis followed by obesity (BMI > 30 Kg/m2); [OR = 3.74 (CI 95% 1.79 – 5.69), p = <0.001], multiple pregnancy [OR= 2.81 (CI 95% 1.70 – 4.64), p = < 0.001] and age > 35 years; [OR =1.09 (CI 95% 0.82 – 1.21), p = 0.026]. Varicose Veins [OR= 0.22 (CI 95% 0.56 – 0.87), p = 0.031], PROM / PPROM [OR= 0.33 (CI 95% 0.12 – 0.91), p = 0.032] and history of using OCP [OR= 0.36 (CI 95% 0.24 – 0.53), p = < 0.001] were the most missed risk factors for receiving VTE prophylaxis respectively. Conclusion: History of VTE, obesity, multiple pregnancy and age > 35 years were the most frequent risk factors for receiving VTE prophylaxis and varicose veins, PROM / PPROM and history of using OCP were the most missed risk factors for receiving VTE prophylaxis.
format Online
Article
Text
id pubmed-6911145
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-69111452019-12-17 A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran Mokhtari, Majid Nasri, Khadijeh Tara, Fatemeh Zarean, Elahe Hantoushzadeh, Sedigheh Radmehr, Mehrnaz Kashanian, Maryam J Family Reprod Health Original Article Objective: The purpose of the present study was a survey of venous thromboembolism (VTE) prophylaxis in obstetrics patients in Iran. Materials and methods: A national, multicenter, non-interventional, prospective study was performed on 1000 women at 11 different parts of Iran. Primary outcome was to assess the situation of VTE prophylaxis in pregnant and postpartum women and the secondary outcome was risk stratification in obstetrics patients and to evaluate the guideline adherence in physician’s practice of VTE prophylaxis. Results: 1,036 women entered the final analysis. The three main VTE risk factors before hospitalization were BMI > 30 kg/m2, history of oral contraceptive (OCP) use, and the age over 35.VTE risk factors upon enrollment were detected in 780 (75.28%) patients. 219 women (28.07%) were deemed eligible for drug prophylaxis, however, only 37 women (17%) received it. A total of 113 (10.9%) patients received VTE prophylaxis, of which 76 (67.25%) women had no clear indications. Concordance between theory and practice was detected with a Cohen’s Kappa coefficient to be 0.74 (p < 0.001), which fell within “good agreement”. Multivariate analysis for association between VTE prophylaxis and VTE risk factors showed that history of VTE [OR = 9.06 (CI 95% 1.16 – 70.8) p = 0.036] was the most frequent risk factor for receiving VTE prophylaxis followed by obesity (BMI > 30 Kg/m2); [OR = 3.74 (CI 95% 1.79 – 5.69), p = <0.001], multiple pregnancy [OR= 2.81 (CI 95% 1.70 – 4.64), p = < 0.001] and age > 35 years; [OR =1.09 (CI 95% 0.82 – 1.21), p = 0.026]. Varicose Veins [OR= 0.22 (CI 95% 0.56 – 0.87), p = 0.031], PROM / PPROM [OR= 0.33 (CI 95% 0.12 – 0.91), p = 0.032] and history of using OCP [OR= 0.36 (CI 95% 0.24 – 0.53), p = < 0.001] were the most missed risk factors for receiving VTE prophylaxis respectively. Conclusion: History of VTE, obesity, multiple pregnancy and age > 35 years were the most frequent risk factors for receiving VTE prophylaxis and varicose veins, PROM / PPROM and history of using OCP were the most missed risk factors for receiving VTE prophylaxis. Tehran University of Medical Sciences 2019-03 /pmc/articles/PMC6911145/ /pubmed/31850094 Text en Copyright © Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mokhtari, Majid
Nasri, Khadijeh
Tara, Fatemeh
Zarean, Elahe
Hantoushzadeh, Sedigheh
Radmehr, Mehrnaz
Kashanian, Maryam
A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
title A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
title_full A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
title_fullStr A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
title_full_unstemmed A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
title_short A Survey of Venous Thromboembolism (VTE) Prophylaxis in Obstetrics Patients in Iran
title_sort survey of venous thromboembolism (vte) prophylaxis in obstetrics patients in iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911145/
https://www.ncbi.nlm.nih.gov/pubmed/31850094
work_keys_str_mv AT mokhtarimajid asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT nasrikhadijeh asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT tarafatemeh asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT zareanelahe asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT hantoushzadehsedigheh asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT radmehrmehrnaz asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT kashanianmaryam asurveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT mokhtarimajid surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT nasrikhadijeh surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT tarafatemeh surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT zareanelahe surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT hantoushzadehsedigheh surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT radmehrmehrnaz surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran
AT kashanianmaryam surveyofvenousthromboembolismvteprophylaxisinobstetricspatientsiniran